MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?
Profile
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.76M
P/E Ratio
N/A
Total Cash
61.26M
Projected Growth
N/A
Total Debt
8.42M
Revenue
4.62M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
1.39
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
Fundamentals
XLO
Capitalization
40.8M
P/E Ratio
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
61.3M
Total Cash/Share
1.39
Total Debt
8.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.10%
Revenue
4.62M
ROE
N/A
Book Value
21M
P/B Ratio
1.94
Cash Flow
N/A
Earnings
-1.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
1.67
Current Revenue Per Employee
31000.00
Dividends Per Share - Security
N/A
EBITDA
-62.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-82.36
Shares Held By Institutions
13.7M
Shares Outstanding - Current
44M
Total Liabilities
53.7M
Total Volume MTD
N/A
Value
1
Gain YTD
68.600
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com